Kazia Therapeutics (ASX:KZA) see promising data from Phase 1 ovarian cancer trial
09 Dec 2020 - Kazia Therapeutics (ASX:KZA) released data from their phase 1 study of Cantrixil in patients with ovarian cancer.
Kazia Therapeutics (ASX:KZA) see promising data from Phase 1 ovarian cancer trial
09 Dec 2020 - Kazia Therapeutics (ASX:KZA) released data from their phase 1 study of Cantrixil in patients with ovarian cancer.